Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Genomics|January 28, 2006
A truncated isoform of TMEFF2 encodes a secreted protein in prostate cancer cellsSteven N Quayle, Marianne D SadarCancer Letters|April 17, 2007
14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgensSteven N Quayle, Marianne D SadarProceedings of the National Academy of Sciences of the United States of America|January 18, 2007
Androgen receptor decoy molecules block the growth of prostate cancerSteven N Quayle, Nasrin R Mawji, Jun Wang, et al.Molecular Cancer Therapeutics|September 21, 2014
In vitro and in vivo interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib in non-Hodgkin lymphoma cellsGirija Dasmahapatra, Hiral Patel, Johnathan Friedberg, et al.Plos One|March 7, 2017
Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitorBrian J North, Ingrid Almeciga-Pinto, David Tamang, et al.Oncotarget|December 8, 2016
Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor modelsPengyu Huang, Ingrid Almeciga-Pinto, Matthew Jarpe, et al.Plos One|January 7, 2017
Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid LeukemiaChengyin Min, Nathan Moore, Jeffrey R Shearstone, et al.BMC Genomics|January 30, 2007
Novel expressed sequences identified in a model of androgen independent prostate cancerSteven N Quayle, Heidi Hare, Allen D Delaney, et al.Journal of Virology|June 15, 2026
Simultaneous TCR and IL-2 agonism selectively enhances epitope-specific CD8 T-cell responses during chronic viral infectionMasao Hashimoto, Mohammad Affan Khan, Akil Akhtar, et al.Blood Advances|November 15, 2018
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemiaKamira Maharaj, John J Powers, Alex Achille, et al.Pageof 3